Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Days Sales Outstanding : 47.97 (As of Mar. 2017)

View and export this data going back to 2009. Start your Free Trial

What is Shandong Luoxin Pharmaceutical Group Stock Co Days Sales Outstanding?

Shandong Luoxin Pharmaceutical Group Stock Co's average Accounts Receivable for the three months ended in Mar. 2017 was $91.7 Mil. Shandong Luoxin Pharmaceutical Group Stock Co's Revenue for the three months ended in Mar. 2017 was $174.4 Mil. Hence, Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding for the three months ended in Mar. 2017 was 47.97.

The historical rank and industry rank for Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding or its related term are showing as below:

SLUXY's Days Sales Outstanding is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 72.34
* Ranked among companies with meaningful Days Sales Outstanding only.

Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding increased from Mar. 2016 (46.77) to Mar. 2017 (47.97).

Shandong Luoxin Pharmaceutical Group Stock Co Days Sales Outstanding Historical Data

The historical data trend for Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Luoxin Pharmaceutical Group Stock Co Days Sales Outstanding Chart

Shandong Luoxin Pharmaceutical Group Stock Co Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Days Sales Outstanding

Get a 7-Day Free Trial

42.17

40.20

38.96

40.13

50.66

Shandong Luoxin Pharmaceutical Group Stock Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Days Sales Outstanding	Get a 7-Day Free Trial															46.77	84.34	70.28	46.11	47.97

Competitive Comparison of Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding falls into.

Shandong Luoxin Pharmaceutical Group Stock Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as

	Days Sales Outstanding (A: Dec. 2016 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2015 )	+	Accounts Receivable (A: Dec. 2016 ))	/	count )	/	Revenue (A: Dec. 2016 )	*	Days in Period
=	( (73.495	+	91.687)	/	2 )	/	595.042	*	365
=	82.591					/	595.042	*	365
=	50.66

Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding for the quarter that ended in Mar. 2017 is calculated as:

	Days Sales Outstanding (Q: Mar. 2017 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2016 )	+	Accounts Receivable (A: Mar. 2017 ))	/	count )	/	Revenue (A: Mar. 2017 )	*	Days in Period
=	( (91.687	+	0)	/	1 )	/	174.402	*	365 / 4
=	91.687					/	174.402	*	365 / 4
=	47.97

Shandong Luoxin Pharmaceutical Group Stock Co (OTCPK:SLUXY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shandong Luoxin Pharmaceutical Group Stock Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shandong Luoxin Pharmaceutical Group Stock Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Luoxin Pharmaceutical Group Stock Co Ltd (OTCPK:SLUXY) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Website

http://www.luoxin.cn

Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products. It is involved in the research and development of LXI-15028, a potassium-competitive acid blocker, which is in phase III development for the treatment of reflux esophagitis and other acid-related gastrointestinal diseases; and LXI-15029, an ATP mTOR kinase inhibitor that acts as potent and selective dual inhibitors of mTORC1 and mTORC2 that controls the process of tumor formation and growth. The company mainly operates in the People's Republic of China.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Headlines

No Headlines